Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: Epidemiology. 2012 Jul;23(4):531–542. doi: 10.1097/EDE.0b013e31825588b8

Table 1.

Summary of household studies of influenza A (H1N1-2009) included in the systematic reviewa

Location
(City, Country)
Study
Period
No. of
Households
No. of
Subjects
Recruitment
Strategyb
Multiple
Index
Index case
ascertainment
Primary
Outcome
All
contacts
Primary SIR, % Secondary
Outcome(s)
Secondary
SIR(s), %
Follow-up duration
of households
Serial
interval (days)
Mean Household size Serology
Collected
Calatayud et al 201018 London, UK Apr 09 – May 09 n/a 47 Cohort N RT-PCR RT-PCR N 17% n/a n/a n/a n/a n/a N
Carcione et al 201119 Western Australia May 09 – Aug 09 595 2184 Case ascertained N RT-PCR RT- PCR/FARI combined N 20% n/a n/a 8 Mean: 3.2, Median: 3 3.8 N
Cauchemez et al 200920 USA Apr 09 – May 09 216 816 Case ascertained N RT-PCR ARI N 13% FARI 10% 7 Mean: 2.9 n/a N
Chang et al 201121 Taiwan Aug 09 – Nov 09 87 223 Case ascertained N RT-PCR + serology RT-PCR + serology Y 27% n/a n/a 7 Mean: 2,.3 n/a Y
Cowling et al 201022 Hong Kong Jul 09 – Aug 09 105 309 Case ascertained N RT-PCR RT-PCR Y 7.8% ARI, FARI 26%, 6.1% 7 Mean: 3.2 n/a Y
Doyle et al 201123 USA Jun 09 53 163 Case ascertained Y FARI FARI N 3.4% n/a n/a n/a Mean: 3 n/a N
France et al 201024 New York, USA Apr 09 322 1042 Case ascertained N RT- PCR/FARI FARI N 11% n/a n/a n/a Median: 3 4.1 N
Goldstein et al 201025 Milwaukee, USA Apr 09 – Jun 09 135 546 Case ascertained N RT-PCR FARI N 13% n/a n/a 7 Mean: 3.32 n/a N
Komiya et al 201027 Osaka, Japan May 09 124 503 Case ascertained N RT-PCR RT-PCR N 3.7% n/a n/a n/a Median: 3 3.1 N
Leung et al 201128 Hong Kong Jun 09 65 270 Case ascertained N RT-PCR RT-PCR N 5.9% n/a n/a 14 Mean: 2.8 n/a N
Looker et al 201029 Victoria, Australia May 09 – Aug 09 132 483 Case ascertained N RT-PCR FARI N 33% n/a n/a n/a n/a 3.9 N
Loustalot et al 201130 Texas, USA May 09 668 640 Cohort N FARI FARI N 3.7% n/a n/a 10 n/a n/a N
Mohamed et al 201131 Riyadh, Saudi Arabia Sep 09 – Oct 09 69 432 Case ascertained N RT-PCR FARI N 17% n/a n/a 12 n/a n/a N
Morgan et al 201032 Texas, USA Apr 09 – May 09 77 349 Case ascertained N RT-PCR/FARI RT-PCR N 4.2% ARI, FARI 13%, 9.3% 9 Median: 4 n/a N
Nishiura et al 201133 Japan May 09 – Feb 10 1547 6156 Case ascertained N RT- PCR/FARI FARI N 11% n/a n/a 7 Mean: 3.1, Median: 3 n/a N
Odaira et al 200934 Kobe, Japan May 09 – Jun 09 97 400 Case ascertained N RT-PCR RT-PCR N 4.1% ARI 4.8% 8 Mean: 2.9, Median: 3 n/a N
Papenburg et al 201035 Quebec, Canada May 09 – Jul 09 42 162 Case ascertained Y RT-PCR RT-PCR + Serology Y 45% RT- PCR, ARI, FARI 38%, 51%, 29% 11 Mean: 3.9, Median: 3 3.8 Y
Pebody et al 201136 UK Apr 09 – Jun 09 259 1046 Case ascertained Y RT-PCR RT-PCR N 8.3% ARI, FARI 16%,11% 7 n/a 4.3 N
Pedroni et al 201037 Chile Jun 09 57 302 Case ascertained N RT-PCR FARI N 37% n/a n/a 14 Mean: 3.6, Median: 3 3.3 N
Savage et al 201138 Ontario, Canada Apr 09 – Jun 09 87 353 Case ascertained N RT-PCR ARI N 20% FARI 10% 14 Median: 3 n/a N
Sikora et al 201039 Alberta, Canada Apr 09 – Jun 09 87 349 Case ascertained N RT-PCR FARI N 30% n/a n/a 14 n/a 4.0 N
Simmerman et al 201140 Bangkok, Thailand Apr 09 – Aug 09 348 1233 Case ascertained N RT-PCR RT-PCR Y 21% FARI 14% 7 Mean: 3.32, Median: 2.94 n/a Y
Suess et al 201041 Germany Apr 09 – Aug 09 36 119 Case ascertained N RT-PCR RT-PCR Y 18% n/a n/a 8 Mean: 2.6, Median: 3 n/a N
Sugimoto et al 201142 Washington, USA May 09 – Jun 09 41 178 Cohort Y RT- PCR/FARI FARI N 5.9% n/a n/a 7 n/a n/a N
van Boven et al 201043 Netherlands Apr 09 – Jun 09 47 156 Case ascertained N RT-PCR RT-PCR N 8.3% n/a n/a 7 n/a n/a N
van Gemert et al 201144 Victora, Australia May 09 – Jun 09 36 167 Retrospective cross- sectional N RT-PCR FARI N 15% n/a n/a 9 Median: 2 3.1 N
a

One study (Jackson et al26) was not included in this table because it provided only supplementary serologic data of a previous study (France et al24). Data are included in the main text.

b

Case ascertained means that index cases were identified through symptom screening or laboratory confirmation; Cohort, index cases were identified from specific populations (e.g. camps, schools, etc) and households without index cases were also followed up

c

Studies in which it would have been possible for more than one person in a household to be identified as index case (i.e. identification of potential co-primary cases).

RT-PCR indicates respiratory specimen positive for influenza by reverse transcription polymerase chain reaction; ARI, acute respiratory illness; FARI, febrile acute respiratory illness; primary SIR, secondary infection risk based on primary outcome; secondary SIR, secondary infection risk based on secondary outcome; Y, yes; N, no; n/a: not applicable.